[Hepatic toxicity in HER-2(+) breast cancer patient under treatment with capecitabine and lapatinib].

MLA

Romero Carreño, Elia, et al. “[Hepatic Toxicity in HER-2(+) Breast Cancer Patient under Treatment with Capecitabine and Lapatinib].” Farmacia Hospitalaria : Organo Oficial de Expresion Cientifica de La Sociedad Espanola de Farmacia Hospitalaria, vol. 40, no. 2, Mar. 2016, pp. 134–36. EBSCOhost, https://doi.org/10.7399/fh.2016.40.2.9360.

APA

Romero Carreño, E., Marcos Rodríguez, J. A., Santana Martínez, S., & de la Cruz Merino, L. (2016). [Hepatic toxicity in HER-2(+) breast cancer patient under treatment with capecitabine and lapatinib]. Farmacia Hospitalaria : Organo Oficial de Expresion Cientifica de La Sociedad Espanola de Farmacia Hospitalaria, 40(2), 134–136. https://doi.org/10.7399/fh.2016.40.2.9360

Chicago

Romero Carreño, Elia, José Antonio Marcos Rodríguez, Sara Santana Martínez, and Luis de la Cruz Merino. 2016. “[Hepatic Toxicity in HER-2(+) Breast Cancer Patient under Treatment with Capecitabine and Lapatinib].” Farmacia Hospitalaria : Organo Oficial de Expresion Cientifica de La Sociedad Espanola de Farmacia Hospitalaria 40 (2): 134–36. doi:10.7399/fh.2016.40.2.9360.